News
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...
The case for Ozempic as a dementia buster is building. Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes.
Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
Ozempic May Lower Dementia Risk in People With Type 2 Diabetes, Study Finds Add this to the growing list of potential perks of the drug. By Korin Miller Published: Jul 18, 2024 7:30 AM EDT ...
Well, this is just one study, so it’s hard to say for sure that Ozempic will lower your risk for dementia. But a 2024 study published in the journal Alzheimer’s & Dementia also linked these ...
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.
The study, published in the Lancet's eClinicalMedicine journal on Thursday, explored more than 100 million medical records of U.S. patients to see if Ozempic increased the risk of several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results